TT
Healthcare & Life Sciences

Thryv Therapeutics

Thryv Therapeutics is a Healthcare & Life Sciences startup based in Canada, most recent round Series A.

Activeseries-a
series-a
Stage

About Thryv Therapeutics

Thryv Therapeutics is a startup based in Canada. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.

Thryv Therapeutics is a clinical-stage biotechnology company developing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for the treatment of inherited cardiac arrhythmias, Long QT Syndrome, and cardiometabolic diseases.

Explore Thryv Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Canada